Page last updated: 2024-10-22

amoxapine and Somatoform Disorders

amoxapine has been researched along with Somatoform Disorders in 1 studies

Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.

Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)

Research Excerpts

ExcerptRelevanceReference
" The author stresses caution in regard to the long term use of amoxapine."1.27Persistent tardive dyskinesia associated with amoxapine therapy--two case reports. ( Huang, CC, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, CC1

Other Studies

1 other study available for amoxapine and Somatoform Disorders

ArticleYear
Persistent tardive dyskinesia associated with amoxapine therapy--two case reports.
    The Hillside journal of clinical psychiatry, 1986, Volume: 8, Issue:2

    Topics: Amoxapine; Depressive Disorder; Dibenzoxazepines; Dyskinesia, Drug-Induced; Female; Humans; Male; Mi

1986